| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.08 |